The Indian government said on Thursday it had signed a deal with local company Biological-E to produce 300 million doses of the coronavirus vaccine for 15 billion rupees ($205.62 million).
The Ministry of Health said in a statement that the vaccine, which is currently undergoing phase III clinical trials, is likely to be available in the next few months.
SOURCE ; Kuwait Offerings
